JP2010536889A5 - - Google Patents

Download PDF

Info

Publication number
JP2010536889A5
JP2010536889A5 JP2010522186A JP2010522186A JP2010536889A5 JP 2010536889 A5 JP2010536889 A5 JP 2010536889A5 JP 2010522186 A JP2010522186 A JP 2010522186A JP 2010522186 A JP2010522186 A JP 2010522186A JP 2010536889 A5 JP2010536889 A5 JP 2010536889A5
Authority
JP
Japan
Prior art keywords
compound
propyl
acid addition
addition salt
acceptable acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010522186A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010536889A (ja
JP5548125B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2008/050214 external-priority patent/WO2009026934A1/en
Publication of JP2010536889A publication Critical patent/JP2010536889A/ja
Publication of JP2010536889A5 publication Critical patent/JP2010536889A5/ja
Application granted granted Critical
Publication of JP5548125B2 publication Critical patent/JP5548125B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010522186A 2007-08-31 2008-08-28 パーキンソン病の治療のために有用なカテコールアミン誘導体 Expired - Fee Related JP5548125B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200701250 2007-08-31
DKPA200701250 2007-08-31
PCT/DK2008/050214 WO2009026934A1 (en) 2007-08-31 2008-08-28 Catecholamine derivatives useful for the treatment of parkinson' s disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014085192A Division JP5802792B2 (ja) 2007-08-31 2014-04-17 パーキンソン病の治療のために有用なカテコールアミン誘導体

Publications (3)

Publication Number Publication Date
JP2010536889A JP2010536889A (ja) 2010-12-02
JP2010536889A5 true JP2010536889A5 (OSRAM) 2011-08-04
JP5548125B2 JP5548125B2 (ja) 2014-07-16

Family

ID=39877715

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2010522186A Expired - Fee Related JP5548125B2 (ja) 2007-08-31 2008-08-28 パーキンソン病の治療のために有用なカテコールアミン誘導体
JP2010522187A Pending JP2010536890A (ja) 2007-08-31 2008-08-28 パーキンソン病の治療のために有用なカテコールアミン誘導体
JP2014021193A Pending JP2014111635A (ja) 2007-08-31 2014-02-06 カテコールアミン誘導体およびそのプロドラッグ
JP2014085192A Expired - Fee Related JP5802792B2 (ja) 2007-08-31 2014-04-17 パーキンソン病の治療のために有用なカテコールアミン誘導体

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2010522187A Pending JP2010536890A (ja) 2007-08-31 2008-08-28 パーキンソン病の治療のために有用なカテコールアミン誘導体
JP2014021193A Pending JP2014111635A (ja) 2007-08-31 2014-02-06 カテコールアミン誘導体およびそのプロドラッグ
JP2014085192A Expired - Fee Related JP5802792B2 (ja) 2007-08-31 2014-04-17 パーキンソン病の治療のために有用なカテコールアミン誘導体

Country Status (29)

Country Link
EP (4) EP2195291A1 (OSRAM)
JP (4) JP5548125B2 (OSRAM)
KR (3) KR20100051834A (OSRAM)
CN (3) CN101842354A (OSRAM)
AR (2) AR068044A1 (OSRAM)
AU (2) AU2008291426B2 (OSRAM)
BR (2) BRPI0815894A2 (OSRAM)
CA (2) CA2691961C (OSRAM)
CL (2) CL2008002558A1 (OSRAM)
CO (2) CO6270232A2 (OSRAM)
CY (1) CY1117326T1 (OSRAM)
DK (1) DK2197883T3 (OSRAM)
EA (2) EA018413B1 (OSRAM)
ES (1) ES2557485T3 (OSRAM)
HR (1) HRP20151334T1 (OSRAM)
HU (1) HUE025882T2 (OSRAM)
IL (1) IL203080A (OSRAM)
MX (1) MX2010002210A (OSRAM)
MY (2) MY148948A (OSRAM)
NZ (2) NZ583551A (OSRAM)
PL (1) PL2197883T3 (OSRAM)
PT (1) PT2197883E (OSRAM)
RS (1) RS54470B1 (OSRAM)
SG (1) SG184711A1 (OSRAM)
SI (1) SI2197883T1 (OSRAM)
TW (2) TWI404702B (OSRAM)
UA (2) UA98804C2 (OSRAM)
WO (2) WO2009026934A1 (OSRAM)
ZA (2) ZA200909191B (OSRAM)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI404702B (zh) * 2007-08-31 2013-08-11 Lundbeck & Co As H 兒茶酚胺衍生物和其前藥
US8067410B2 (en) 2008-06-27 2011-11-29 H. Lundbeck A/S Phenolic and catecholic amines and prodrugs thereof
EP2303851A1 (en) * 2008-06-27 2011-04-06 H. Lundbeck A/S Novel phenolic and catecholic amines and prodrugs thereof
TW201036949A (en) * 2009-02-27 2010-10-16 Lundbeck & Co As H Treatment of dyskinesia related disorders
TW201035054A (en) * 2009-02-27 2010-10-01 Lundbeck & Co As H Methods of administering (4aR, 10aR)-1-n-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[g]quinoline-6,7-diol and pharmaceutical compositions thereof
KR102712887B1 (ko) 2017-11-24 2024-10-02 하. 룬드벡 아크티에셀스카브 파킨슨병의 치료에 사용하기 위한 새로운 카테콜아민 전구약물
WO2020070099A1 (en) 2018-10-02 2020-04-09 H. Lundbeck A/S Administration of catecholamine prodrugs in combination with a 5-ht2b antagonist
US11111263B2 (en) 2019-05-20 2021-09-07 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11130775B2 (en) 2019-05-20 2021-09-28 H. Lundbeck A/S Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11168056B2 (en) * 2019-05-20 2021-11-09 H. Lundbeck A/S Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol
US11104697B2 (en) 2019-05-20 2021-08-31 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
CN113677675B (zh) * 2019-05-21 2024-07-26 H.隆德贝克有限公司 用于治疗帕金森病的新儿茶酚胺前药
JP7562562B2 (ja) * 2019-05-21 2024-10-07 ハー・ルンドベック・アクチエゼルスカベット パーキンソン病の治療に使用するための新規なカテコールアミンプロドラッグ
US12398106B2 (en) 2019-05-21 2025-08-26 H. Lundbeck A/S Catecholamine carbamate prodrugs for use in the treatment of parkinson's disease
EP3972970A1 (en) 2019-05-21 2022-03-30 H. Lundbeck A/S New catecholamine prodrugs for use in the treatment of parkinson's disease
CN114478298B (zh) * 2020-11-12 2024-09-27 成都西岭源药业有限公司 一种造影剂碘佛醇的纯化方法
WO2022106352A1 (en) 2020-11-17 2022-05-27 H. Lundbeck A/S New catecholamine prodrugs for use in the treatment of parkinson's disease
CN113620760A (zh) * 2021-09-07 2021-11-09 张家口思睿凯科技有限公司 一种电子盐反应液和不饱和芳香烃类化合物的还原方法
WO2025078574A1 (en) * 2023-10-12 2025-04-17 Integrative Research Laboratories Sweden Ab NOVEL ESTERS OF 1,2,3,4,4a,5,6,7,8,9,10,10a-DODECAHYDROBENZO[g]QUINOLIN-6-OL COMPOUNDS AND USES THEREOF

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4080456A (en) * 1971-10-26 1978-03-21 Schering Aktiengesellschaft Diacylapomorphines
CH648300A5 (en) * 1979-06-22 1985-03-15 Sandoz Ag Phenanthrene derivatives and medicaments containing them
US4543256A (en) * 1982-03-17 1985-09-24 Northeastern University (-)-10,1L Methylenedioxy-N-N-propylnoraporphine and methods employing it for inhibiting the effects of epileptic seizures and for prevention and treatment of duodenal ulcers
WO1990012574A1 (en) * 1989-04-25 1990-11-01 Northeastern University Dopamine agonist compounds
JPH03163078A (ja) * 1989-08-30 1991-07-15 Sankyo Co Ltd 光学活性な縮環複素環化合物及びその製法
TW357143B (en) * 1995-07-07 1999-05-01 Novartis Ag Benzo[g]quinoline derivatives
EP0861234A1 (en) * 1995-11-10 1998-09-02 Novo Nordisk A/S Enantiomers of cis-benz e]indole compounds, their preparation and utility as dopamine-d3 receptor selective agents
CN1241998A (zh) * 1996-10-30 2000-01-19 伊莱利利公司 苯并[f]喹啉酮的合成
SE0102036D0 (sv) 2001-06-08 2001-06-08 Axon Biochemicals Bv Pharmaceutical formulation for the efficient administration of apomorphine, 6aR- (-) -N- Propyl- norapomorphine and their derivatives and pro-drugs thereof
SE0002934D0 (sv) * 2000-08-17 2000-08-17 Axon Biochemicals Bv New aporphine esters and in their use in therapy
AR030357A1 (es) * 2000-08-18 2003-08-20 Lundbeck & Co As H Derivados 4 -, 5 -, 6 - y 7-indol
US20050090518A1 (en) * 2003-10-24 2005-04-28 Nastech Pharmaceutical Company Inc. Method for treating parkinson's disease using apomorphine and apomorphine prodrugs
TWI404702B (zh) * 2007-08-31 2013-08-11 Lundbeck & Co As H 兒茶酚胺衍生物和其前藥

Similar Documents

Publication Publication Date Title
JP2010536889A5 (OSRAM)
JP2010504343A5 (OSRAM)
JP2011518833A5 (OSRAM)
JP2009545527A5 (OSRAM)
JP2014500861A5 (OSRAM)
JP2009535462A5 (OSRAM)
JP2008533007A5 (OSRAM)
JP2006526031A5 (OSRAM)
JP2010501534A5 (OSRAM)
JP2013032389A5 (OSRAM)
JP2010529994A5 (OSRAM)
JP2006515626A5 (OSRAM)
JP2012506896A5 (OSRAM)
JP2012512907A5 (OSRAM)
JP2010534684A5 (OSRAM)
JP2009149903A5 (OSRAM)
JP2009502743A5 (OSRAM)
JP2011527560A5 (OSRAM)
JP2012144574A5 (OSRAM)
JP2009533348A5 (OSRAM)
JP2007302683A5 (OSRAM)
JP2010095546A5 (OSRAM)
JP2010501474A5 (OSRAM)
JP2009531376A5 (OSRAM)
JP2007302689A5 (OSRAM)